APYX Bull Call Spread Strategy
APYX (Apyx Medical Corporation), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019.
APYX (Apyx Medical Corporation) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $160.8M, a beta of 1.35 versus the broader market, a 52-week range of 1.335-4.5, average daily share volume of 158K, a public-listing history dating back to 2019, approximately 220 full-time employees. These structural characteristics shape how APYX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.35 indicates APYX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a bull call spread on APYX?
A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width.
Current APYX snapshot
As of May 15, 2026, spot at $4.08, ATM IV 95.50%, IV rank 43.64%, expected move 27.38%. The bull call spread on APYX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this bull call spread structure on APYX specifically: APYX IV at 95.50% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 27.38% (roughly $1.12 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated APYX expiries trade a higher absolute premium for lower per-day decay. Position sizing on APYX should anchor to the underlying notional of $4.08 per share and to the trader's directional view on APYX stock.
APYX bull call spread setup
The APYX bull call spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With APYX near $4.08, the first option leg uses a $4.08 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed APYX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 APYX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $4.08 | N/A |
| Sell 1 | Call | $4.28 | N/A |
APYX bull call spread risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit.
APYX bull call spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bull call spread on APYX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use bull call spread on APYX
Bull call spreads on APYX reduce the cost of a bullish APYX stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
APYX thesis for this bull call spread
The market-implied 1-standard-deviation range for APYX extends from approximately $2.96 on the downside to $5.20 on the upside. A APYX bull call spread caps both the risk and the reward of a bullish position; relative to an outright long call on APYX, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current APYX IV rank near 43.64% is mid-range against its 1-year distribution, so the IV signal is neutral; the bull call spread thesis on APYX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, APYX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to APYX-specific events.
APYX bull call spread positions are structurally moderately bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. APYX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move APYX alongside the broader basket even when APYX-specific fundamentals are unchanged. Long-premium structures like a bull call spread on APYX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current APYX chain quotes before placing a trade.
Frequently asked questions
- What is a bull call spread on APYX?
- A bull call spread on APYX is the bull call spread strategy applied to APYX (stock). The strategy is structurally moderately bullish: A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width. With APYX stock trading near $4.08, the strikes shown on this page are snapped to the nearest listed APYX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are APYX bull call spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit. For the APYX bull call spread priced from the end-of-day chain at a 30-day expiry (ATM IV 95.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a APYX bull call spread?
- The breakeven for the APYX bull call spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current APYX market-implied 1-standard-deviation expected move is approximately 27.38%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bull call spread on APYX?
- Bull call spreads on APYX reduce the cost of a bullish APYX stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
- How does current APYX implied volatility affect this bull call spread?
- APYX ATM IV is at 95.50% with IV rank near 43.64%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.